Cited by 74Vitamin C and Antioxidants ResearchRespiratory viral infections researchPediatric health and respiratory diseases

Evaluation of the efficacy of ascorbic acid in prophylaxis of induced rhinovirus 44 infection in man

Schwartz, A. R., Togo, Y., Hornick, R. B., Tominaga, S., Gleckman, R. A.·1973·Journal of Infectious Diseases

Abstract

Twenty-one healthy, susceptible adult male volunteers were enrolled in a double-blind study designed for evaluation of the prophylactic efficacy of ascorbic acid (3 g daily) in induced rhinovirus 44 infection of the upper respiratory tract. While in continuous isolation, 11 men received 1 g of ascorbic acid three times daily, and 10 men received a placebo for two weeks, after which an intranasal inoculum containing 100 tcid50 of rhinovirus 44 was administered. Each man continued to receive the same dose of medication for one week after the viral challenge. All participants subsequently developed typical illness due to rhinovirus. Similar levels of antibody in serum, nasal washings, and sputum developed in all subjects. Nasal shedding of virus and the flow of the nasal mucociliary blanket were unaffected by the ingestion of ascorbic acid. No prophylactic benefit was demonstrated from the daily ingestion of 3 g of ascorbic acid in induced rhinovirus 44 infection in man.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/128.4.500

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Schwartz 1973 found a reduction in common cold severity in the vitamin C group.

    “Schwartz 1973 found a reduction in common cold severity in the vitamin C group”

    From Vitamin C for preventing and treating the common cold (2013) · cites this paper as Schwartz 1973

    The Results (p. 2) found no significant difference in illness, sign, or symptom scores between the vitamin C and placebo groups. The Discussion (p. 5) concludes that vitamin C did not significantly ameliorate the induced rhinoviral illness, contrary to the claimed reduction in severity. (LLM, conf=0.90)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Schwartz 1973's finding indicates a biological effect of vitamin C.

    “also indicating a biological effect.”

    From Vitamin C for preventing and treating the common cold (2013) · cites this paper as Schwartz 1973

  • Doses of 3 g/day vitamin C have not prevented natural colds in ordinary people (Karlowski 1975) or laboratory colds (Walker 1967; Schwartz 1973).

    “Doses of 3 g/day vitamin C have not prevented natural colds in ordinary people (Karlowski 1975) or laboratory colds (Walker 1967; Schwartz 1973).”

    From Vitamin C for preventing and treating the common cold (2013) · cites this paper as Schwartz 1973

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schwartz, A. R., Togo, Y., Hornick, R. B., Tominaga, S., & Gleckman, R. A.
Affiliations
University of Maryland, Baltimore (US)
Venue
Journal of Infectious Diseases
Published
1973-10-01
Volume
128
Issue
4
Pages
500-505
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2127187139
Cited by
74
References
13
Citations by year
2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2017: 2 · 2014: 1 · 2013: 1
FWCI
7.85
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
  • Health Sciences › Health Professions › Emergency Medical Services › Pediatric health and respiratory diseases
Keywords
vitamin C, common cold, upper respiratory tract infection, prophylaxis, serum antibody response, nasal shedding, mucociliary clearance
MeSH terms
Adult, Ascorbic Acid, Clinical Trials as Topic, Common Cold, Humans, Male, Middle Aged, Placebos, Rhinovirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review